招金矿业上半年产能加速释放 业绩增长强劲
招金矿业上半年产能加速释放 业绩增长强劲

香港, 2024年8月24日 – (亚太商讯 via SeaPRwire.com) — 中国领先的黄金生产商–招金矿业股份有限公司（股份代号：1818，以下简称“招金矿业”或“公司”）公布截至2024年6月30日止之半年业绩。上...

祖龙娱乐发布2024年中期业绩

财务摘要︰ – 2024年上半年收益为人民币439.4百万元，较2023年同期增长9.2%。其中，综合游戏发行及运营业务收益同比增长25.0%至人民币 376.5百万元，占总收益的85.7%。– 2024年上半年毛利...

2nd ASEAN Battery Technology Conference Strengthens Southeast Asia Battery Ecosystem Through New Collaborations and Expansion
2nd ASEAN Battery Technology Conference Strengthens Southeast Asia Battery Ecosystem Through New Collaborations and Expansion

SINGAPORE, Aug 24, 2024 – (ACN Newswire via SeaPRwire.com) – The 2nd ASEAN Battery Technology Conference (ABTC) returned and strengthened the commitment to develop a close knitted battery development ecosystem among the Southeast Asian countries. Hosted in Singapore this year by the Singapore Battery Consortium at Singapore at the Shangri-La Rasa Sentosa between 21st and... » read more

Kyrgyzstan Education Ministry Partners Singapore’s Marshall Cavendish Education with Plans to Adopt Singapore Maths and Science Education Titles in the Country
Kyrgyzstan Education Ministry Partners Singapore’s Marshall Cavendish Education with Plans to Adopt Singapore Maths and Science Education Titles in the Country

ISSYK KUL, Kyrgyzstan, Aug 24, 2024 – (ACN Newswire via SeaPRwire.com) – The Ministry of Education and Science of the Kyrgyz Republic has partnered with Singapore’s Marshall Cavendish Education (MCE) to introduce key training programmes and education resources to its schools throughout the country. The partnership seeks to instill key skillsets and content knowledge to strengthen... » read more

Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1

Cambridge, MA, Aug 24, 2024 – (ACN Newswire via SeaPRwire.com) – Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formulation of its COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1. “We appreciate the Ministry of... » read more

InfoComm India 2024: The Largest Edition of the Pro AV Exhibition to Date
InfoComm India 2024: The Largest Edition of the Pro AV Exhibition to Date

MUMBAI, INDIA, Aug 23, 2024 – (ACN Newswire via SeaPRwire.com) – InfoComm India, India’s foremost professional audiovisual (Pro AV) exhibition, is set to return to Mumbai from 3-5 September 2024 at the Jio World Convention Centre (JWCC). This year, InfoComm India 2024 expands beyond Pavilions 1 to 3 at JWCC, incorporating Jasmine Hall (at Level... » read more

2nd ASEAN Battery Technology Conference Announces New Collaborations and Expansion to Strengthen Southeast Asia Battery Ecosystem
2nd ASEAN Battery Technology Conference Announces New Collaborations and Expansion to Strengthen Southeast Asia Battery Ecosystem

SINGAPORE, Aug 23, 2024 – (ACN Newswire via SeaPRwire.com) – The 2nd ASEAN Battery Technology Conference (ABTC) returned and strengthened the commitment to develop a close knitted battery development ecosystem among the Southeast Asian countries. Hosted in Singapore this year by the Singapore Battery Consortium at Singapore at the Shangri-La Rasa Sentosa between 21st and 23rd... » read more

Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024

Seoul, Korea, Aug 23, 2024 – (ACN Newswire via SeaPRwire.com) – Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured three prestigious awards at the esteemed Korea Biopharma Excellence Awards (KBEA) 2024. The KBEA event, held in conjunction with the 13th Annual Biologics... » read more

Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT)

SHANGHAI, Aug 22, 2024 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced the launch of an Investigator-Initiated Clinical Trial (IIT) for a personalized mRNA cancer vaccine, EVM16, under the study EVM16CX01, at the Peking... » read more